Pulmatrix, Inc. (Nasdaq: PULM) ("Pulmatrix") and Eos SENOLYTIX, Inc. ("Eos"), a biotechnology company developing novel gerotherapeutic peptides targeting mitochondrial dysfunction in aging-related ...
Regional versions being recorded to showcase musical diversity ...
Explore how Raman spectroscopy supports quantitative pharmaceutical analysis by enabling accurate measurement of active ...
Combined company to operate as Eos SENOLYTIX, a first-in-class anti-aging biotechnology company $19 million financings to advance lead clinical candidate PTC-2105 for sarcopenia and age-related ...
A US court ruling has thrown a major vaccine advisory panel into uncertainty, halting proposed changes and sparking debate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results